Phibro Animal Health (PAHC)
(Delayed Data from NSDQ)
$12.73 USD
+0.29 (2.33%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $12.71 -0.02 (-0.16%) 6:28 PM ET
2-Buy of 5 2
A Value B Growth A Momentum A VGM
Brokerage Reports
Phibro Animal Health Corporation [PAHC]
Reports for Purchase
Showing records 1 - 20 ( 247 total )
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Solid 2Q24; Maintains Outlook with Lower Feed Prices Supportive
Provider: Roth Capital Partners, Inc.
Analyst: WRIGHT B
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Company: Phibro Animal Health Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department